Fludarabine and mitoxantrone: Effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders-Reference-Cited by-同舟云学术

Fludarabine and mitoxantrone: Effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders

Published:2001-10 Issue:10 Volume:12 Page:1455-1460
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Seymour J.F.,Grigg A.P.,Szer J.,Fox R.M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/12/10/1455/19478890/12-10-1455.pdf

Reference45 articles.

1. A Revised European–American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group;Harris;Blood,1994

2. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma. including Waldenström’s macroglobulinemia: A clinical, morphologic, and biologic spectrum of similar disorders;Pangalis;Semin Hematol,1999

3. Fludarabine: A new agent with major activity against chronic lymphocytic leukemia;Keating;Blood,1989

4. Phase II trial of fludarabine phosphate in lymphoma: An effective new agent in low-grade lymphoma;Redman;J Clin Oncol,1992

5. Fludarabine therapy in macroglobulinemic lymphoma;Kantarjian;Blood,1990

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Agent Effect and Polychemotherapy Regimens for Malignant Tumor Treatment - A Review;Galician Medical Journal;2022-06-01

2. Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Lymphoproliferative Disorders;Clinical Lymphoma Myeloma and Leukemia;2012-02

3. Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden;Cancer;2010-08-19

4. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma;Cancer;2008-11-15

5. Indolent Lymphomas Other than Follicular and Marginal Zone Lymphomas;Hematology/Oncology Clinics of North America;2008-10